Chronic myelogenous leukemia - chronic phase

Clinical trials for Chronic myelogenous leukemia - chronic phase explained in plain language.

Never miss a new study

Get alerted when new Chronic myelogenous leukemia - chronic phase trials appear

Sign up with your email to follow new studies for Chronic myelogenous leukemia - chronic phase, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 2 Completed 1

New pill shows promise for Tough-to-Treat leukemia

Disease control Completed

This study tested a new drug called asciminib in 56 adults with chronic myeloid leukemia (CML) whose cancer had not responded well to other treatments. The drug is taken as a pill and aims to control the disease. The main goal was to check safety and side effects over 24 weeks, w…

Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE

Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Jun 27, 2026 07:54 UTC

Chronic myelogenous leukemia - chronic phase

Get alerted when new Chronic myelogenous leukemia - chronic phase trials appear

New pill shows promise for Tough-to-Treat leukemia